Hem › Kronisk myeloisk leukemi › Washington
Kliniska studier för Kronisk myeloisk leukemi i Washington
11 studier för Kronisk myeloisk leukemi söker deltagare vid platser i Washington.
Städer i Washington
Officiell studietext (engelska)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- och 19 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1136, Edmonds
- Ascentage Investigative Site #1135, Issaquah
- Ascentage Investigative Site #1806, Seattle
- och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06423911Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Seattle Childrens Hospital, Seattle
RekryterarFas 2
Ålder 1 till 18 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07354074Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RekryterarFas 2
6 Months – 65 Years · Alla kön · Uppdaterad 22 juli 2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Fred Hutchinson Cancer Research Center, Seattle
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RekryterarFas 2Friska volontärer välkomna
6 Months · Alla kön · Uppdaterad 29 maj 2026 · NCT04195633HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RekryterarFas 1
Upp till ålder 80 · Alla kön · Uppdaterad 18 maj 2026 · NCT03326921A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Fred Hutchinson Cancer Center, Seattle
RekryterarFas 2
Ålder 18 till 66 · Alla kön · Uppdaterad 17 mars 2026 · NCT06859424A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Fred Hutchinson Cancer Center, Seattle
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 12 jan. 2026 · NCT06163430Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Fred Hutchinson Cancer Research Center, Seattle
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 5 nov. 2025 · NCT04260022TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
- Fred Hutchinson Cancer Center, Seattle
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 21 feb. 2025 · NCT06088888Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.